- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Breast Care 11.5 (2016): S. 313 - 314
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2016
- Creator
- URN
-
urn:nbn:de:bvb:29-opus4-107148
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fasching, Peter Andreas
- Gaß, Paul
- Hein, Alexander
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2016
Other Objects (12)
Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Integrative radiomics models for improved response assessment to neoadjuvant systemic treatment in breast cancer
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?
Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Current and future role of neoadjuvant therapy for breast cancer
Advances in breast cancer detection
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: A cost estimate with real-world data
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Integrative radiomics models for improved response assessment to neoadjuvant systemic treatment in breast cancer
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?
Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Current and future role of neoadjuvant therapy for breast cancer
Advances in breast cancer detection
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: A cost estimate with real-world data
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Integrative radiomics models for improved response assessment to neoadjuvant systemic treatment in breast cancer
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Is breast surgery necessary for breast carcinoma in complete remission following neoadjuvant chemotherapy?
Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Current and future role of neoadjuvant therapy for breast cancer
Advances in breast cancer detection
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited
The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: A cost estimate with real-world data